THE ROGERS,WILL PHENOMENON - STAGE MIGRATION AND NEW DIAGNOSTIC-TECHNIQUES AS A SOURCE OF MISLEADING STATISTICS FOR SURVIVAL IN CANCER

被引:1325
作者
FEINSTEIN, AR
SOSIN, DM
WELLS, CK
机构
[1] YALE UNIV, SCH MED, DEPT MED, I-456 SHM, POB 3333, NEW HAVEN, CT 06510 USA
[2] YALE UNIV, SCH MED, DEPT EPIDEMIOL, NEW HAVEN, CT 06510 USA
[3] YALE UNIV, SCH MED, CLIN EPIDEMIOL UNIT, NEW HAVEN, CT 06510 USA
[4] VET ADM MED CTR, W HAVEN, CT 06516 USA
关键词
D O I
10.1056/NEJM198506203122504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A cohort of patients with lung cancer 1st treated in 1977 had higher 6 mo. survival rates for the total group and for subgroups in each of the 3 main TNM stages (tumor, nodes and metastases) than a cohort treated between 1953 and 1964 at the same institutions. The more recent cohort had undergone many new diagnostic imaging procedures. According to the old diagnostic data for both cohorts, the recent cohort had a prognostically favorable zero-time shift. By demonstrating metastases that had formerly been silent and unidentified, the new technological data resulted in a stage migration. Many patients who previously would have been classified in a good stage were assigned to a bad stage. Because the prognosis of those who migrated, although worse than that for other members of the good-stage group, was better than that for other members of the bad-stage group, survival rates rose in each group without any change in individual outcomes. When classified according to symptom stages that would be unaltered by changes in diagnostic techniques, the 2 cohorts had similar survival rates.
引用
收藏
页码:1604 / 1608
页数:5
相关论文
共 23 条
[1]  
BOYD NF, 1978, CLIN INVEST MED, V1, P25
[2]   PRE-THERAPEUTIC MORBIDITY IN THE PROGNOSTIC STAGING OF ACUTE-LEUKEMIA [J].
BOYD, NF ;
CLEMENS, JD ;
FEINSTEIN, AR .
ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (03) :324-328
[3]   A NEW CLINICAL INDEX OF GROWTH-RATE IN THE STAGING OF BREAST-CANCER [J].
CHARLSON, ME ;
FEINSTEIN, AR .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :527-536
[4]   SOME PITFALLS IN EVALUATION OF SCREENING PROGRAMS [J].
FEINLEIB, M ;
ZELEN, M .
ARCHIVES OF ENVIRONMENTAL HEALTH, 1969, 19 (03) :412-&
[5]  
Feinstein A., 1985, Clinical epidemiology: the architecture of clinical research
[6]   EPIDEMIOLOGY OF CANCER THERAPY .4. EXTRACTION OF DATA FROM MEDICAL RECORDS [J].
FEINSTEIN, AR ;
PRITCHETT, JA ;
SCHIMPFF, CR .
ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (05) :571-+
[7]   EPIDEMIOLOGY OF CANCER THERAPY .3. MANAGEMENT OF IMPERFECT DATA [J].
FEINSTEIN, AR ;
PRITCHETT, JA ;
SCHIMPFF, CR .
ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (04) :448-+
[8]   EPIDEMIOLOGY OF CANCER THERAPY .2. CLINICAL COURSE - DATA DECISIONS AND TEMPORAL DEMARCATIONS [J].
FEINSTEIN, AR ;
PRITCHETT, JA ;
SCHIMPFF, CR .
ARCHIVES OF INTERNAL MEDICINE, 1969, 123 (03) :323-+
[9]   SYMPTOMS AS AN INDEX OF BIOLOGICAL BEHAVIOUR AND PROGNOSIS IN HUMAN CANCER [J].
FEINSTEIN, AR .
NATURE, 1966, 209 (5020) :241-+
[10]   CANCER OF LARYNX - NEW STAGING SYSTEM AND A RE-APPRAISAL OF PROGNOSIS AND TREATMENT [J].
FEINSTEIN, AR ;
SCHIMPFF, CR ;
ANDREWS, JF ;
WELLS, CK .
JOURNAL OF CHRONIC DISEASES, 1977, 30 (05) :277-305